The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PMB-CT01 (BAFFR-CAR T cell) therapy to examine preliminary safety and clinical responses in patients with B-cell malignancies who are ineligible for or failed CD19-directed therapy, including CD19-negative disease.
 
Lihua Elizabeth Budde
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Kite/Gilead; Loxo/Lilly; Novartis; nurix; Roche/Genentech
Research Funding - Amgen; AstraZeneca; Merck; MustangBio
Patents, Royalties, Other Intellectual Property - CCR4 CAR T cells for treatment of patients with CCR4 positive cancer.; CD33CAR for treatment of patients with CD33+ acute myeloid leukemia.
Travel, Accommodations, Expenses - AstraZeneca; Kite/Gilead; Roche/Genentech
 
Marissa Del Real
No Relationships to Disclose
 
John H. Baird
Honoraria - Curio Science; Olson Research Group
Consulting or Advisory Role - Gerson Lehrman Group
Speakers' Bureau - Kite/Gilead
Research Funding - Genentech/Roche (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Regeneron (Inst)
 
Lu Chen
No Relationships to Disclose
 
Joo Y Song
No Relationships to Disclose
 
Xiuli Wang
Consulting or Advisory Role - Pepromene
 
Swetha Kambhampati
Consulting or Advisory Role - Abbvie; Ipsen
Research Funding - ADC Therapeutics; Genentech/Roche; Genmab
Travel, Accommodations, Expenses - Kite/Gilead
 
Alan Macias
No Relationships to Disclose
 
Teresa Kim
No Relationships to Disclose
 
Sylvia Dulan
No Relationships to Disclose
 
Baishakhi Barva
No Relationships to Disclose
 
Min Guan
No Relationships to Disclose
 
Ruby Espinosa
No Relationships to Disclose
 
Sandrine Puverel
Consulting or Advisory Role - Pepromene
 
Katrin Tiemann
No Relationships to Disclose
 
Hazel (Ting-Ying) Cheng
Employment - Pepromene bio Inc.
Leadership - Pepromene Bio Inc
Stock and Other Ownership Interests - Pepromene Bio Inc.
Travel, Accommodations, Expenses - Pepromene Bio Inc.
 
Stephen J. Forman
Stock and Other Ownership Interests - Lixte Biotechnology; MustangBio
Consulting or Advisory Role - Alimera Sciences; Lixte Biotechnology; MustangBio; MustangBio
Research Funding - MustangBio
Patents, Royalties, Other Intellectual Property - MustangBio
 
Larry W. Kwak
Stock and Other Ownership Interests - InnoLife; Pepromene; TheraTest Laboratories
Consulting or Advisory Role - Pepromene; Renhaim; Sellas Life Sciences
Research Funding - Pepromene; Renhaim
 
Ibrahim Aldoss
Honoraria - Agios; Amgen; Jazz Pharmaceuticals; Kite, a Gilead Company; Pfizer; Syndax; Takeda; WUGEN, Inc.
Consulting or Advisory Role - Agios; Amgen; Jazz Pharmaceuticals; Kite, a Gilead Company; Pfizer; Syndax; Takeda; WUGEN, Inc.
Research Funding - Abbvie; MacroGenics